Task: Answer the multiple-choice question.
Query: Which drug has a -4.773% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) C=CCc1ccccc1OCC(O)CN1CCN(C(=O)OCC)CC1.Cl
b.) O=C(NCCSc1c[nH]c2ccccc12)c1ccc2c(c1)OCO2
c.) CC(Sc1nnc2ccccn12)C(=O)N1CCc2ccccc2C1
Answer: c. CC(Sc1nnc2ccccn12)C(=O)N1CCc2ccccc2C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(Sc1nnc2ccccn12)C(=O)N1CCc2ccccc2C1
CC(Sc1nnc2ccccn12)C(=O)N1CCc2ccccc2C1
1-(3,4-dihydro-1H-isoquinolin-2-yl)-2-([1,2,4]triazolo[4,3-a]pyridin-3-ylsulfanyl)propan-1-one